Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of ...
A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...
The post Pancreatic Cancer Vaccine Shows Potential in Early Trial appeared first on Reason.com.
The Republican who was Illinois governor throughout the 1990s said he was diagnosed in mid-January and has undergone three ...
The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the ...
The FDA granted RMAT designation to nogapendekin alfa and CAR-NK for reversing lymphopenia in patients with cancer, with ...
Former Illinois Gov. Jim Edgar announced in a statement Monday that he is battling pancreatic cancer. In the statement, Edgar ...
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...
Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...
Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...
Pancreatic cancer reprograms nerve cells to fuel its growth, but blocking these connections can shrink tumors and boost ...
5h
HealthDay on MSNNanosensor Assay Promising for Pancreatic Cancer DetectionA rapid nanosensor assay that measures serum protease cleavage of a target-probe nanosensor can identify pancreatic du ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results